Brief: Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029
18/06/2026 08:16
BRIEF-Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029 June 18 (Reuters) - Mabion SA MABP.WA:
SIGNS ANNEX TO PRODUCTION AGREEMENT WITH NOVAVAX
EXTENDS PRODUCTION AGREEMENT WITH NOVAVAX TO END OF 2029
Source text: ID:nEMbW6hJRa
Further company coverage: MABP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Mabion SA
See all newsBrief: Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029
Brief: Mabion Signs Deal With Oddifact Sas On Preparing Mabioncd20 For FDA Consultation
Brief: Mabion Q1 Net Loss 9.7 Million Zlotys
Brief: Mabion Signs LoI With Oddifact On Use Of MabionCD20 Drug For Orphan Diseases
Brief: Mabion FY Net Loss 62.6 Million Zlotys